An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
A Prospective Audit of Perioperative Parameters of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)
Sponsor: Tata Memorial Centre
A observational or N/A phase clinical study on Colorectal Cancer and Ovarian Cancer, this trial is actively recruiting participants. The trial is conducted by Tata Memorial Centre and has accumulated 14 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Dec 2024 — Present [monthly]
Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
-
May 2022 — Sep 2023 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Nov 2021 — May 2022 [monthly]
Recruiting
-
May 2021 — Nov 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Apr 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2018 — Apr 2020 [monthly]
Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tata Memorial Centre
For direct contact, visit the study record on ClinicalTrials.gov .